Summit Trail Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Buy |
5,871
+588
| +11% | +$262K | 0.04% | 213 |
|
|
2025
Q1 | $2.56M | Buy |
5,283
+874
| +20% | +$424K | 0.08% | 73 |
|
|
2024
Q4 | $1.78M | Buy |
4,409
+1,145
| +35% | +$461K | 0.07% | 90 |
|
|
2024
Q3 | $1.52M | Buy |
3,264
+383
| +13% | +$178K | 0.04% | 200 |
|
|
2024
Q2 | $1.35M | Buy |
2,881
+372
| +15% | +$174K | 0.04% | 187 |
|
|
2024
Q1 | $1.05M | Buy |
2,509
+410
| +20% | +$171K | 0.03% | 212 |
|
|
2023
Q4 | $854K | Sell |
2,099
-260
| -11% | -$106K | 0.03% | 200 |
|
|
2023
Q3 | $820K | Buy |
2,359
+692
| +42% | +$241K | 0.03% | 191 |
|
|
2023
Q2 | $587K | Buy |
1,667
+944
| +131% | +$332K | 0.02% | 234 |
|
|
2023
Q1 | $228K | Buy |
+723
| New | +$228K | 0.01% | 367 |
|
|
2019
Q1 | – | Sell |
-1,396
| Closed | -$231K | – | 133 |
|
|
2018
Q4 | $231K | Sell |
1,396
-1,695
| -55% | -$280K | 0.08% | 93 |
|
|
2018
Q3 | $596K | Buy |
3,091
+274
| +10% | +$52.8K | 0.13% | 89 |
|
|
2018
Q2 | $479K | Sell |
2,817
-6,512
| -70% | -$1.11M | 0.17% | 74 |
|
|
2018
Q1 | $956K | Buy |
9,329
+1,140
| +14% | +$117K | 0.16% | 137 |
|
|
2017
Q4 | $1.34M | Buy |
+8,189
| New | +$1.34M | 0.17% | 120 |
|